"FDA Greenlights OTC Birth Control Pill, Empowering Women's Reproductive Choices"

The US Food and Drug Administration (FDA) has approved the first over-the-counter birth control pill, allowing American women and girls to purchase contraceptive medication without a prescription. The once-a-day Opill by Perrigo will be available for sale in early 2023 with no age restrictions. Hormone-based pills have been the most common form of birth control in the US, but until now, they required a prescription. The move aims to improve access to contraception, particularly for those facing barriers such as cost, time off work, and childcare. Women's health advocates hope this decision will pave the way for more over-the-counter birth control options and eventually for abortion pills as well.